MeDirect participates in a Training Session on Money Laundering and Funding of Terrorism Typologies

The British High Commission, in collaboration with the Financial Intelligence Analysis Unit (FIAU) Malta and Malta Financial Services Authority, organised a full day training session on Money Laundering and Funding of Terrorism Typologies on 18th April, 2023. 

Martin Xerri, MeDirect’s Senior Financial Manager and Money Laundering Reporting Officer (MLRO) was part of the panel discussing Financial Crime Compliance from an International perspective. He discussed MeDirect’s current model and future plans. He also pointed out the importance of sharing knowledge between regulators, other financial institutions and the general public, stressing that Public-Private Partnerships (PPP) and information sharing are vital to effectively fighting financial crime.  

During the panel session there were also discussions relating to issues experienced by local banks in continuing Malta’s and their institutions’ strategies in mitigating risks and the importance of transaction monitoring. They also discussed sectors like crypto and gaming and the local banks’ risk appetite within these areas. 

The discussion also evolved on the importance of implementing the monitoring requirements of international bodies in addition to what’s legally binding in Malta (e.g. US OFAC). These requirements have an operational impact on correspondent bank relationships and their subsequent risk appetite when dealing with local banks.

Franklin Templeton Thoughts: The Fed -quantitative tightening or quantitative easing?

Can the Fed balance its objective of fighting inflation—and help save banks in turmoil? Stephen Dover, Head of Franklin Templeton Institute, opines.

Can central banks simultaneously provide liquidity to banks suffering sharp deposit withdrawals while also slowing money and credit creation by raising interest rates? In essence, can central banks quantitatively tighten and quantitatively ease at the same time?

The actions of the Federal Reserve (Fed) in recent weeks raise these questions. Since the Silicon Valley Bank (SVB) failure, the Fed’s balance sheet has swelled by over US$290 billion as the central bank acted as a “lender of last resort” to US banks teetering on the edge of failure. The increase in the Fed’s balance sheet via loans to troubled banks unwound nearly half of its 2022 balance sheet contraction (quantitative tightening).

For investors, the question arises: Can the Fed save banks and achieve its inflation objective at the same time? Must it choose between competing aims?

The answer is yes, the Fed can do both. No trade-off is required. In what follows, we explain why and how—but we add a caveat. Just because the Fed can multitask does not guarantee that it will multitask well. Central banking is always more art than science, and the Fed has a challenging job ahead of it.

Monetary policy versus crisis management

There are several keys to understanding how the Fed can address two challenges simultaneously.

Quantitative easing (QE) is a monetary policy strategy central banks use, when appropriate, to purchase securities (i.e., bonds), to boost commercial bank reserves and their capacity to lend. Quantitative easing also has a second impact; namely via direct purchases, it lowers longer-term interest rates. Both mechanisms stimulate economic activity.

The opposite process, called quantitative tightening (QT), takes place when central banks unwind their balance sheets by selling bonds, which reduces commercial bank reserves (and hence lending capacity) and pushes up longer-term interest rates.

When banks such as SVB experience bank runs, their depositors are shifting their preference (in real time and very fast) from bank deposits to either cash or to bank deposits with safer banks. To prevent a disorderly bank failure, the Fed will make loans to banks suffering large depositor withdrawals. But those loans don’t create excess reserves or fresh lending opportunities. Rather, loans from the Fed replenish diminished reserves just as they replace deposits on the liability side of banks’ balance sheets. These actions don’t increase the money supply or loanable reserves, nor do they lead to a fall in economy-wide interest rates.

Of course, some depositors are merely switching deposits from failing banks to healthy ones, theoretically enabling those healthier banks to make more loans. But two factors will offset that impact. First, troubled banks requiring loans from the Fed to stay afloat will also cut their lending. The Fed also can simultaneously lend to struggling banks while selling bonds to healthy banks, withdrawing some of the Fed’s reserves and lending capacity. The Fed is not operationally or in any other way constrained from acting to prevent disorderly bank failures while also adjusting policy to meet its dual mandate of stable prices and maximum employment.

Presently, the Fed—despite the actions taken to stabilize a few troubled US banks—continues to sell its holdings of US Treasuries and mortgaged-backed securities (MBS) at a rate of US$95 billion per month. Its actions to prevent a disorderly collapse of various commercial banks has had no impact on its pursuit of QT. The net result is fewer bank reserves in aggregate, a tightening of credit conditions and—as we saw at the conclusion of the most recent Federal Open Market Committee meeting—a willingness (and ability) to keep hiking interest rates.

Here are some of the implications of the latest Fed actions:

  • The Fed can have its cake and eat it too. While the massive increase in the Fed balance sheet reserves provides additional liquidity to select banks, its actions are not akin to QE. The Fed is responding to specific increases in money demand and portfolio shifts from deposits to cash at a few banks by making loans, not buying securities. And those banks are being wound down or sold off; they are not expanding their lending capacity. Meanwhile, the Fed is otherwise withdrawing bank reserves via asset sales (QT) and is hiking interest rates.

  • The discount window does not involve a new money injection. Banks that borrow at the Fed’s discount window must deposit collateral in exchange for a loan. As a result, the Fed is exchanging less-liquid assets for more liquid ones—bonds for cash. This increases bank reserves only for banks that are experiencing reserve losses. And when properly conducted, is not increasing system-wide liquidity or lending. That is even more likely if, as can be expected, those troubled banks are forced to shrink their operations.

  • Banks are given access to liquidity. The new facility the Fed has established, the Bank Term Funding Program (BTFP), is designed to help trouble banks meet depositor and creditor demands without having to sell assets (i.e., their bond portfolios) at a loss. In doing so, the Fed is lending at par against bonds that may be worth less than par, which could be seen as a sign of easing. But that measure should not be seen in isolation. To begin, it is a facility for banks facing funding problems, which are ones unlikely to be increasing their stock of illiquid loans. Second, The Fed can absorb whatever additional system-wide liquidity BTFP creates through the sale of bonds to the remainder of the banking sector via open market operations.

  • Long-term rates are probably not affected. Because open market operations can offset emergency lending facilities in monetary policy terms, the impact of the Fed’s actions should not have a material impact on interest rates, lending, spending or broader asset prices. The fact that nominal interest rates have fallen since the travails of SVB is not, therefore, due to a change in the Fed’s monetary policy stance, but rather reflects the probability that banking stresses will do some of the Fed’s work for it; namely, it will lead to some additional tightening of credit conditions as all banks adopt a more cautious approach toward their clients.

  • QT continues. QT is a monetary-policy tool, whereas emerging lending facilities are intended to alleviate specific strains in the banking system. The pace of QT remains unchanged, as close observers of the Fed recognize. For example, according to the median forecast from the Survey of Primary Dealers, the Fed’s balance sheet is expected to fall from 35% to 25% of nominal US gross domestic product by the end of next year.

  • How important is deposit reallocation? As noted, some of the shift of depositors out of at-risk banks found a new home in large banks, which are perceived to be “too big to fail.” Those banks clearly have higher deposits and reserves, placing them in a position to increase lending or securities purchases. Some might think the result is akin therefore to monetary stimulus. In all likelihood, that is wrong. The Fed is aware of deposit reallocation and has the tools to address it. Via bond sales, it can absorb any excess liquidity and, in doing so, it can raise interest rates. The Fed forcefully demonstrated that ability by hiking rates 25 basis points in March, even though jitters in the banking system had not fully abated.

In sum, we can say two things with equal conviction.

First, there is nothing that prevents the Fed from saving banks and simultaneously pursuing its monetary policy objective of tightening to fight inflation. The Fed has enough instruments to do both.

Second, just because it can do both does not ensure that it will be successful in achieving its aims. Other banking or financial ructions could yet emerge. Many observers view the situation in US commercial real estate with trepidation, as a potential flashpoint for the next crisis. Equally, the Fed could still get it wrong on the economy. It might overtighten and produce an unnecessarily deep recession, or it might not tighten enough and end up having to battle endemic inflation.

The good news is the Fed has the tools to meet the challenge. The question is, will it use them to good effect?


Franklin Templeton Disclaimer:

All investments involve risks, including the possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The positioning of a specific portfolio may differ from the information presented herein due to various factors, including, but not limited to, allocations from the core portfolio and specific investment objectives, guidelines, strategy and restrictions of a portfolio.

Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions.

Bond prices generally move in the opposite direction of interest rates. Thus, as prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline. Investments in lower-rated bonds include higher risk of default and loss of principal. Changes in the credit rating of a bond, or in the credit rating or financial strength of a bond’s issuer, insurer or guarantor, may affect the bond’s value. In general, an investor is paid a higher yield to assume a greater degree of credit risk. The risks associated with higher-yielding, lower-rated debt securities include higher risk of default and loss of principal. Investments in foreign securities involve special risks including currency fluctuations, economic instability and political developments.

Investments in emerging markets, of which frontier markets are a subset, involve heightened risks related to the same factors, in addition to those associated with these markets’ smaller size, lesser liquidity and lack of established legal, political, business and social frameworks to support securities markets. To the extent a strategy focuses on particular countries, regions, industries, sectors or types of investment from time to time, it may be subject to greater risks of adverse developments in such areas of focus than a strategy that invests in a wider variety of countries, regions, industries, sectors or investments.

Any companies and/or case studies referenced herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. The information provided is not a recommendation or individual investment advice for any particular security, strategy, or investment product and is not an indication of the trading intent of any Franklin Templeton managed portfolio.

IMPORTANT LEGAL INFORMATION

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.

Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Franklin Templeton Investment Management Limited (FTIML). No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Market Update by Liontrust – Q1 2023

Liontrust GF High Yield Bond Fund is manufactured by Liontrust Fund Partners LLP and represented in Malta by MeDirect Bank (Malta) plc.

Market review

The global high yield market returned of 3.3% in US dollar terms in Q1 2023. US high yield market returned 3.7% while the European market returned 3.3%. Both markets performed well despite the market volatility around the collapse of SVB and the Credit Suisse/UBS merger in March. These events raised concerns around the banking sector, giving an indication as to whether the monetary policy actions in the US were working and therefore resulting in some companies failing to battle the higher interest rate environment.

Performance was also supported by the stall in primary market issuance, with issuers shelving deals until a more suitable market environment presents itself. The high yield market doesn’t have a looming maturity wall to address as many issuers have refinanced and will only start to have more meaningful debt maturities to address from 2025 onwards. Corporate earnings were on the whole good and default rates are rising but from a very low level. The US and European high yield markets saw ratings decompression, where CCC bonds outperformed BB and B bonds in January and February, before it switched and better-quality bonds outperformed CCC bonds in March.

When hedging via interest rate futures, we took the opportunity to hedge some of the natural, albeit low, level of duration that exists in high yield bonds, using. When yields moved higher, these were closed out.

Fund review

Over the quarter, the Liontrust GF High Yield Bond Fund (A1, accumulation class, total return in euros) produced a return of 2.7% versus the ICE BAML Global High Yield index’s (euro hedged) 2.7%*.

Relative to index, the best performing sectors in the Fund in Q1 2023 were capital goods, telecommunications, healthcare and basic industry. Strong contributors to stock picking include Ardagh (a packaging company), VirginMedia, Profine (a PVC window frame manufacturer), and two healthcare names, Cheplapharm and Catalent. The Catalent bonds were marked seven points up on the back of rumours that it is an acquisition target for Danaher (an investment grade rated company).

Areas where our relative underweight position was a drag to performance were in more cyclical sectors, such as energy and leisure. This shouldn’t come as a surprise as the Fund has a bias towards less cyclical defensive credits.

During the quarter the Fund participated in four new issues, one of which was Sealed Air. Sealed Air is a leading global provider of packaging solutions integrating high-performance materials, automation, equipment and services. The company is well diversified both geographically and with its customer base. Financial performance has been good and it has clearly demonstrated its ability to acquire and integrate businesses in order to expand successfully. The US dollar-denominated bonds are rated Ba2/BB+ and were priced attractively below par with a 6.875% coupon.

We participated in a euro perpetual new issue from Swiss bank Julius Baer. The bond was rated Baa3 with a 6.625% yield, which we believe was attractive for the structure given the defensiveness of the underlying business. The aftermath of the complete write-down of Credit Suisse AT1 led to the underperformance of this bond, which was one of the drags in the quarter, alongside Barclays AT1. Elsewhere, although the real estate sector has been less dramatic than last year, stock selection was mixed in the quarter. The Fund had a positive contribution from Castellum and Peach, with both companies raising equity, though CPI Property continues to be a drag despite the fact its operational performance has been good.

We participated in a new issue from existing holding TransDigm, a manufacturer of engineered aerospace components for commercial airlines, aircraft maintenance facilities, original equipment manufacturers and various agencies of the US government. We particularly like the strong margins of the business and positive free cash flow generation. The new issue is higher up the capital structure; a US dollar-denominated bond rated Ba3/B+ with a 6.75% coupon.

Azelis is the most recent deal we participated in. It is a leading global distributor of specialty chemicals and food ingredients. Azelis operates in more than 50 countries and has a presence in more than 40 industry sectors. It has a resilient business, growth opportunities both organically and through M&A, as well as market leading positions in highly fragmented markets. Its financial performance has also been good. The bonds are euro-denominated, rated BB+ and came with a coupon of 5.75%.

Outlook

The global high yield market benefitted from a strong rally at the beginning of the year before experiencing some volatility towards the end of the quarter. Risks such as the collapse of SVB and the Credit Suisse/UBS merger are typically more likely to emerge in an environment where rates are higher and funding conditions tighter. In the Credit Suisse situation where its AT1 debt was written off, investor sentiment of the sub-asset class has taken a turn. Concerns were raised around the language behind AT1 debt in general and how they would be treated if a bank got into trouble. Since the wobble, we have seen the retracement of AT1 debt and believe that investors are convinced that the recent volatility experienced is down to idiosyncratic elements rather than a banking crisis or the beginning of a domino effect of failing companies sparked by the Fed’s monetary policy tightening cycle. These fears of broader contagion from the banking turmoil have been alleviated by governments and central banks.

In the Fund, we have around 3% AT1 exposure and are comfortable with the credits we have exposure to. Some have been marked down purely because of contagion, but we believe the bonds will perform well over time. As the sub-asset class has the potential to be volatile, we are limiting our overall exposure. Primary issuance has been minimal during the last quarter, and the issuers that have come to market are predominantly using funds for general corporate purposes rather than to finance M&A activity; they have also typically been from higher rated credits. We have yet to see lower quality credits come to market, which is in part an indication of the market environment but also a reflection of investors’ appetite for higher quality credits. The deals that have come to market have been oversubscribed, demonstrating that there is demand for new issues but at a price. This strong technical around lack of issuance in the asset class has also helped the positive performance of the asset class year-to-date.

With default rates still low, corporate fundamentals are generally looking resilient with no immediate debt maturity wall to address. We believe our bias towards better quality, less cyclical credits should be beneficial in this market environment. However, we are mindful of the potential mild recessionary period in the latter part of the year, and feel we have invested in credits that are well positioned to deal with such a headwind. The Fund is currently offering yield of almost 10% for sterling-based investors, which we view this as an attractive entry point for investors.

 


Liontrust Key risks & Disclaimers:

Past performance is not a guide to future performance. Do remember that the value of an investment and the income generated from them can fall as well as rise and is not guaranteed, therefore, you may not get back the amount originally invested and potentially risk total loss of capital.

The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Investment in the GF High Yield Bond Fund involves foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The value of fixed income securities will fall if the issuer is unable to repay its debt or has its credit rating reduced. Generally, the higher the perceived credit risk of the issuer, the higher the rate of interest. Bond markets may be subject to reduced liquidity. The Fund may invest in emerging markets/soft currencies and in financial derivative instruments, both of which may have the effect of increasing volatility. The Fund may invest in derivatives. The use of derivatives may create leverage or gearing. A relatively small movement in the value of a derivative’s underlying investment may have a larger impact, positive or negative, on the value of a fund than if the underlying investment was held instead.

Issued by Liontrust Fund Partners LLP (2 Savoy Court, London WC2R 0EZ), authorised and regulated in the UK by the Financial Conduct Authority (FRN 518165) to undertake regulated investment business.

This document should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, faxed, reproduced, divulged or distributed, in whole or in part, without the express written consent of Liontrust. Always research your own investments and (if you are not a professional or a financial adviser) consult suitability with a regulated financial adviser before investing.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Liontrust Fund Partners LLP. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.